PURPOSE: To determine the incidence of significant postoperative intraocular pressure(IOP) elevation and other adverse medical events during the first postoperative day in patients undergoing inpatient vitreoretinal s...PURPOSE: To determine the incidence of significant postoperative intraocular pressure(IOP) elevation and other adverse medical events during the first postoperative day in patients undergoing inpatient vitreoretinal surgery. Design: Noncomparative interventional case series. Participants: Two hundred two consecutive patients were admitted prospectively as inpatients after vitreoretinal surgery (vitrectomy and/or scleral buckling). Methods: Intraocular pressure was measured preoperatively, 5 to 12 hours postoperatively, and on postoperative day 1. Additionally, pain, nausea, and serious systemic adverse events were monitored. Results: Seventeen patients (8.4%)-had a 5-to 12-hour IOP measurement above 29 mmHg. Thirty patients (14.8%) had a postoperative day 1 IOP measurement above 29 mmHg. Three patients (1.5%) required a parenteral narcotic to achieve adequate analgesia. Nine patients (4.5%)-utilized a parenteral antiemetic for nausea control. Six patients (3.0%) had a hyperglycemicevent. No serious systemic adverse events occurred in the early postoperative period. Conclusions: The incidence of a significant IOP spike or systemic adverse events in the early postoperative period in patients undergoing vitreoretinal surgery is low.展开更多
文摘PURPOSE: To determine the incidence of significant postoperative intraocular pressure(IOP) elevation and other adverse medical events during the first postoperative day in patients undergoing inpatient vitreoretinal surgery. Design: Noncomparative interventional case series. Participants: Two hundred two consecutive patients were admitted prospectively as inpatients after vitreoretinal surgery (vitrectomy and/or scleral buckling). Methods: Intraocular pressure was measured preoperatively, 5 to 12 hours postoperatively, and on postoperative day 1. Additionally, pain, nausea, and serious systemic adverse events were monitored. Results: Seventeen patients (8.4%)-had a 5-to 12-hour IOP measurement above 29 mmHg. Thirty patients (14.8%) had a postoperative day 1 IOP measurement above 29 mmHg. Three patients (1.5%) required a parenteral narcotic to achieve adequate analgesia. Nine patients (4.5%)-utilized a parenteral antiemetic for nausea control. Six patients (3.0%) had a hyperglycemicevent. No serious systemic adverse events occurred in the early postoperative period. Conclusions: The incidence of a significant IOP spike or systemic adverse events in the early postoperative period in patients undergoing vitreoretinal surgery is low.
